See every side of every news story
Published loading...Updated

Trump administration drops Biden plan for Medicare to cover weight-loss drugs

  • The Trump administration has decided not to cover obesity medications under Medicare's Part D, as reported by the Centers for Medicare and Medicaid Services.
  • Biden proposed a rule to include coverage for medications like Zepbound and Wegovy, but the rule is not implemented yet.
  • Polling indicates about 40% of U.S. Adults support Medicare and Medicaid covering weight-loss drugs, with concerns about costs and side effects raised by health policy organizations.
  • States that provide coverage for GLP-1 drugs are managing costs by implementing prescribing limits and meeting certain patient criteria.
Insights by Ground AI
Does this summary seem wrong?

298 Articles

All
Left
43
Center
183
Right
17
The Avery Journal-TimesThe Avery Journal-Times
+13 Reposted by 13 other sources
Lean Left

Biden Plan To Expand Obesity Drug Coverage Is Rejected

Key Takeaways

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

NBC Dallas-Fort Worth broke the news in Fort Worth, United States on Friday, April 4, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.